homehealthcare News

Podcast: Cracking the biosimilar code with Biocon’s Kiran Mazumdar Shaw

Podcast: Cracking the biosimilar code with Biocon’s Kiran Mazumdar Shaw

The Indian pharmaceuticals space’s growth has been severely hobbled by acute pricing pressure in the US generics market. The next leg of growth will be defined by companies that focus on high margins and complex drugs like biosimilars. Kiran Mazumdar Shaw, CMD of Biocon, was instrumental in putting India on the biosimilar map. In the first episode of #TheMedicineBox, Shaw breaks down the world of biosimilars and the opportunity it presents. Shaw also weighs in on the vital challenges in the Indian pharma space. Happy Listening!

Recommended Articles

View All
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!

Top Budget Opinions

    Most Read

    Market Movers

    View All
    Top GainersTop Losers
    CurrencyCommodities
    CompanyPriceChng%Chng